Selexipag Market Size to Reach USD 4.12 Billion by 2031 | Key Trends, Growth Drivers & Forecast Insights
The global Selexipag market is entering a high-growth phase, driven by rising pulmonary arterial hypertension (PAH) prevalence, innovation in targeted oral therapies, and accelerated adoption of patient-centric treatment models. The market, valued at USD 1.67 billion in 2024, is projected to reach USD 4.12 billion by 2031, expanding at a robust 14.1% CAGR, significantly outperforming the...
0 Commenti 0 condivisioni 59 Views 0 Anteprima
flexartsocial.com https://www.flexartsocial.com